Novel Personalized Management Approaches in Rheumatoid Arthritis

Program Overview

This case-based activity demonstrates the most effective approaches to instituting, monitoring, and revising therapy in the clinical setting and discusses new and emerging agents on the horizon. Test yourself against your peers and find out how the experts manage their patients.

Credit Expired
CE Credit Expired

Target Audience

Rheumatologists – Relevant Terms: Rheumatoid Arthritis

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Utilize appropriate risk-assessment and monitoring tools for patients with rheumatoid arthritis (RA) to assess disease activity and direct individualized management decisions
  • Integrate new and emerging IL-6 directed therapies in RA for individualized treatment plans based on safety and efficacy data, patient selection data, and the rationale for targeting the IL-6 pathway
  • Incorporate strategies for a collaborative approach to RA care that includes a multidisciplinary team of health professionals and patient preferences into treatment selection

Activity Faculty

Vibeke Strand, MD, MACR, FACP

Vibeke Strand, MD, MACR, FACP

Adjunct Clinical Professor
Division of Immunology/Rheumatology
Stanford University School of Medicine
Stanford, CA

Martin Jan Bergman, MD, FACR, FACP, FCPP

Martin Jan Bergman, MD, FACR, FACP, FCPP

Clinical Associate Professor, Medicine
Drexel University School of Medicine
Philadelphia, PA

Eric M. Ruderman, MD

Eric M. Ruderman, MD

Professor, Medicine
Department of Rheumatology
Northwestern University
Chicago, IL

Supporter Statement

Provider Statement

Disclosure of Financial Relationships

Faculty

Planners and Managers

Method of Participation and Request for Credit

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2024. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | www.RMEI.com | (866) 770-RMEI

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources